Ciprofloxacin and levofloxacin resistance among methicillin-sensitive staphylococcus aureus isolates from keratitis and conjunctivitis

American Journal of Ophthalmology

Volumn 137, Issue 3, 2004, Pages 453-458

  Marangon, Fabiana B ^a   Miller, Darlene ^a   Muallem, Marcus S ^a   Romano, Andre C ^a   Alfonso, Eduardo C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONJUNCTIVA; CONJUNCTIVITIS; CONTROLLED STUDY; CORNEA; HUMAN; HUMAN TISSUE; KERATITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS INFECTION; STATISTICAL SIGNIFICANCE;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; CONJUNCTIVITIS, BACTERIAL; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FLUOROQUINOLONES; HUMANS; KERATITIS; METHICILLIN; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 1542297336     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2003.10.026     Document Type: Article

References (35)

1. Aswad M.I., John T., Barza M., Kenyon K., Baum J. Bacterial adherence to extended wear soft contact lenses. Ophthalmology. 97:1990;296-302.
2. Gudmundsson O.G., Ormerod L.D., Kenyon K.R., et al. Factors influencing predilection and outcome of bacterial keratitis. Cornea. 8:1989;115-121.
3. Asbell P., Stenson L.S. Ulcerative keratitis survey of 30 years' laboratory experience. Arch Ophthalmol. 100:1982;77-80.
4. Ormerod L.D., Hertzmark E., Gomez D.S., et al. Epidemiology of microbial keratitis in southern California. Ophthalmology. 94:1987;1322-1333.
5. Tuft S.J., Matheson M. In vitro antibiotic resistance in bacterial keratitis in London. Br J Ophthalmol. 84:2000;687-691.
6. Knauf H.P., Sivany R., Southern P.M., et al. Susceptibility of corneal and conjunctival pathogens to ciprofloxacin. Cornea. 15:1996;66-71.
7. Alexandrakis G., Alfonso E.C., Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology. 107:2000;1497-1502.
8. Frohlich S.J., Mino de Kaspar H., Grasbon T., et al. Bacterial keratitis. Microbiological analysis as a principle for therapeutic recommendations. Ophthalmologe. 96:1999;459-464.
9. Schaefer F., Bruttin O., Zografos L., et al. Bacterial keratitis a prospective clinical and microbiological study. Br J Ophthalmol. 85:2001;842-847.
10. Tazawa H., Ooishi M. MRSA ocular infections. Nippon Rinsho. 50:1992;1122-1126.
11. Hackbarth C.J., Chambers H.F. Methicillin-resistant staphylococci detection methods and treatment of infections. Antimicrob Agents Chemother. 33:1989;995-999.
12. Barza M. Use of quinolones for treatment of ear and eye infections. Eur J Clin Microbiol Infect Dis. 10:1991;296-303.
13. Neu H.C. Microbiologic aspects of fluoroquinolones. Am J Ophthalmol. 112:(4 Suppl):1991;15S-24S.
14. Baum J., Barza M. The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis 1970-2000. Cornea. 19:2000;659-672.
15. Blumberg H.M., Rimland D., Carall D.J., et al. Rapid development of ciprofloxacin resistance in methicillin-susceptible and resistant Staphylococcus aureus. J Infect Dis. 163:1991;1279-1285.
16. Maple P., Hamilton-Miller J., Brumfitt W. Ciprofloxacin resistance in methicillin and gentamicin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 8:1989;622-624.
17. Shalit I., Berger S.A., Gorea A., et al. Widespread quinolone resistance among methicillin resistant Staphylococcus aureus isolates in a general hospital. Antimicrob Agents Chemother. 33:1989;593-594.
18. Daum T.E., Schaberg D.R., Terpenning M.S., et al. Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrob Agents Chemother. 34:1990;1862-1863.
19. George R.C., Ball L.C., Norbury P.B. Susceptibility to ciprofloxacin of nosocomial gram-negative bacteria and staphylococci isolated in the UK. Antimicrob Chemother. 26:(F Suppl):1990;145-156.
20. Ball P. Emerging resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus clinical significance and therapeutic approaches. J Antimicrob Chemother. 26:(F Suppl):1990;165-179.
21. Liesegang T.J., Forster R.K. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol. 90:1980;38-47.
22. Alfonso E., Mandelbaum S., Fox M.J., Forster R.K. Ulcerative keratitis associated with contact lens wear. Am J Ophthalmol. 101:1986;429-433.
23. Kowalski R.P., Pandya A.N., Karenchak L.M., et al. An in vitro resistance study of levofloxacin, ciprofloxacin, and ofloxacin using keratitis isolates of Staphylococcus aureus and Pseudomonas aeroginosa. Ophthalmology. 108:2001;1826-1829.
24. Isaacs R.D., Kunke P.J., Cohen R.L., et al. Ciprofloxacin resistance in epidemic methicillin-resistant Staphylococcus aureus. Lancet. 2:1988;843.
25. Raviglione M.C., Boyle J.F., Mariuz P., et al. Ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus in an acute-care hospital. Antimicrob Agents Chemother. 34:1990;2050-2054.
26. Marangon FB, Miller D, Alfonso EC. Impact of prior therapy on the recovery and frequency of ocular pathogens. Cornea, In press.
27. Wilson P. Linezolid a new antibiotic for gram-positive infections. Hosp Med. 62:2001;682-686.
28. French G. Linezolid. Int J Clin Pract. 55:2001;59-63.
29. Tsiodras S., Gold H.S., Sakoulas G., et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet. 358:2001;207-208.
30. Lawyer M.C., Lawyer E.Z. Linezolid and reversible myelosuppression. JAMA. 286:2001;1974.
31. Dajes J.J., Hume E.B.H., Moreau J.M., et al. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit. Invest Ophthalmol Vis Sci. 41:2000;1432-1437.
32. Mather R., Karenchak L.M., Romanowski E.G., et al. Fourth generation fluoroquinolones new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 133:2002;463-466.
33. Malathum K., Singh K.V., Murray B.E. In vitro activity of moxifloxacin, a new 8-methoxyquinolone, against gram-positive bacteria. Diagn Microbiol Infect Dis. 35:1999;127-133.
34. Blondeau J.M., Laskowski R., Bjarnason J., et al. Comparative in vitro activity of gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin and trovafloxacin against 4151 Gram-negative and Gram-positive organisms. Int J Antimicrob Agents. 14:2000;45-50.
35. Abb J. In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin- resistant Staphylococcus aureus comparative evaluation by the E test and a broth microdilution method. Diagn Microbiol Infect Dis. 43:2002;319-321.